Exelixis
EXEL
#1851
Rank
A$15.43 B
Marketcap
A$57.56
Share price
-0.10%
Change (1 day)
-7.70%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company